Benitec Biopharma
D

BNTC

8.75000
USD
0.14
(1.63%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
1,538
الربح لكل سهم
-1
العائد الربحي
-
P/E
-9
حجم السوق
305,281,489

العنوان: Benitec Biopharma

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or haveno effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.